[
    [
        {
            "time": "",
            "original_text": "万泰生物：万泰沧海近日收到赛诺菲发来的《关于终止新型轮状病毒疫苗许可协议的通知函》，万泰沧海已根据协议约定收到预付授权许可费1000万美元并履行了相关义务，此次交易的终止不影响该笔款项的收取权利，不会",
            "features": {
                "keywords": [
                    "万泰生物",
                    "赛诺菲",
                    "新型轮状病毒疫苗",
                    "许可协议终止",
                    "1000万美元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "万泰生物：终止授权赛诺菲巴斯德公司进行新型轮状病毒疫苗开发、生产及商业化",
            "features": {
                "keywords": [
                    "万泰生物",
                    "赛诺菲巴斯德",
                    "新型轮状病毒疫苗",
                    "终止授权"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "九价HPV“一苗难求”催生黄牛月入上万，国产何时可实现替代",
            "features": {
                "keywords": [
                    "九价HPV",
                    "一苗难求",
                    "黄牛",
                    "国产替代"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]